BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34088015)

  • 1. Generation of an iPSC line (GWCMCi002-A) from an X-linked Alport syndrome patient with a hemizygous splicing mutation (NM_000495.4, c. 1517-1 G > T) in the COL4A5 gene.
    Gao X; Li G; Deng H; Feng W; Li Y; Liu M; Li Y
    Stem Cell Res; 2021 May; 53():102388. PubMed ID: 34088015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an induced pluripotent stem cell line (SHCDNRi001-A) from a patient with X-linked Alport syndrome carrying a heterozygous p.G409S (c. 1225 G > A) mutation in the COL4A5 gene.
    Sun L; Zhang J; Kuang XY; Kang YL; Wu Y; Huang WY
    Stem Cell Res; 2020 May; 45():101833. PubMed ID: 32416580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of two induced pluripotent stem cell lines from patients with X-linked Alport syndrome.
    Ma Y; Wang Z; Gao M; Liu X; Sun W; Gong Y; Sun G; Liu G
    Stem Cell Res; 2021 May; 53():102343. PubMed ID: 33878711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of the induced pluripotent stem cell line (NCKDi004-A) from a 17-year-old patient with Alport syndrome carrying a homozygous mutation in COL4A3 gene.
    Wu H; Wang G; Gao E; Zhang L; Zhu Y; Zhang J; Liu Z
    Stem Cell Res; 2021 Oct; 56():102557. PubMed ID: 34626894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
    Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
    Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
    Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K
    Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
    Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
    Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case with somatic and germline mosaicism in COL4A5 detected by multiplex ligation-dependent probe amplification in X-linked Alport syndrome.
    Aoto Y; Kise T; Nakanishi K; Nagano C; Horinouchi T; Yamamura T; Ishiko S; Sakakibara N; Shima Y; Morisada N; Iijima K; Nozu K
    CEN Case Rep; 2020 Nov; 9(4):431-436. PubMed ID: 32621070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between mRNA expression level of the mutant COL4A5 gene and phenotypes of XLAS females.
    Wang Y; Zhang H; Ding J; Wang F
    Exp Biol Med (Maywood); 2007 May; 232(5):638-42. PubMed ID: 17463160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mosaicism is a pitfall in the diagnosis of "sporadic" X-linked Alport syndrome.
    Okamoto T; Nozu K; Iijima K; Ariga T
    J Nephrol; 2019 Feb; 32(1):155-159. PubMed ID: 30062677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reassessing the pathogenicity of c.2858G>T(p.(G953V)) in COL4A5 Gene: report of 19 Chinese families.
    Zhang Y; Ding J; Wang S; Zhang H; Zhong X; Liu X; Xu K; Wang F
    Eur J Hum Genet; 2020 Feb; 28(2):244-252. PubMed ID: 31576025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A wave of deep intronic mutations in X-linked Alport syndrome.
    Boisson M; Arrondel C; Cagnard N; Morinière V; Arkoub ZA; Saei H; Heidet L; Kachmar J; Hummel A; Knebelmann B; Bonnet-Dupeyron MN; Isidor B; Izzedine H; Legrand E; Couarch P; Gribouval O; Bole-Feysot C; Parisot M; Nitschké P; Antignac C; Dorval G
    Kidney Int; 2023 Aug; 104(2):367-377. PubMed ID: 37230224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing for X-linked Alport syndrome by direct sequencing of COL4A5 cDNA from hair root RNA samples.
    Tazón-Vega B; Ars E; Burset M; Santín S; Ruíz P; Fernández-Llama P; Ballarín J; Torra R
    Am J Kidney Dis; 2007 Aug; 50(2):257.e1-14. PubMed ID: 17660027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an urine-derived induced pluripotent stem cell line from a 5-year old X-linked Alport syndrome (X-LAS) patient.
    Guo X; Ji W; Niu C; Ding Y; Chen Z; Chen C; Tong H; Han Z; Chu M
    Stem Cell Res; 2020 Dec; 49():102085. PubMed ID: 33202306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Splicing Abnormalities and Genotype-Phenotype Correlation in X-linked Alport Syndrome.
    Horinouchi T; Nozu K; Yamamura T; Minamikawa S; Omori T; Nakanishi K; Fujimura J; Ashida A; Kitamura M; Kawano M; Shimabukuro W; Kitabayashi C; Imafuku A; Tamagaki K; Kamei K; Okamoto K; Fujinaga S; Oka M; Igarashi T; Miyazono A; Sawanobori E; Fujimaru R; Nakanishi K; Shima Y; Matsuo M; Ye MJ; Nozu Y; Morisada N; Kaito H; Iijima K
    J Am Soc Nephrol; 2018 Aug; 29(8):2244-2254. PubMed ID: 29959198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a COL4A5 heterozygous mutation human embryonic stem cell line (WAe009-A-58) using an episomal vector-based CRISPR/Cas9 system.
    Tian L; Wu F; Bai R; Ma S; Zheng H; Liu WJ; Wang Y
    Stem Cell Res; 2021 Aug; 55():102481. PubMed ID: 34419749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
    Malone AF; Funk SD; Alhamad T; Miner JH
    Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Functional Analysis in vitro of 2 COL4A5 Splicing Mutations at the Same Site in 2 Unrelated Alport Syndrome Chinese Families.
    Lv X; Wu WQ; Zhang JX; Miao LF; Yu BZ; Chen FF; Cui YX; Xia ZK; Liu ZH; Li XJ
    Cytogenet Genome Res; 2020; 160(5):238-244. PubMed ID: 32659759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic evaluation of synonymous COL4A5 variants in X-linked Alport syndrome using a minigene assay.
    Horinouchi T; Yamamura T; Minamikawa S; Nagano C; Sakakibara N; Nakanishi K; Shima Y; Morisada N; Ishiko S; Aoto Y; Nagase H; Takeda H; Rossanti R; Ishimori S; Kaito H; Matsuo M; Iijima K; Nozu K
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1342. PubMed ID: 32543079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of a novel mutation in COL4A5 gene from a Chinese family with X-linked alport syndrome].
    Peng CL; Liang H; Z ou QL; Wang J; Liu CS; Zhang XF; Chen J; Hu SN
    Yi Chuan Xue Bao; 2004 Nov; 31(11):1190-5. PubMed ID: 15651669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.